Decernotinib

DB12566InvestigationalSmall molecule

Decernotinib has been used in trials studying the treatment of Drug Interactions and Rheumatoid Arthritis.

Chemical structure of Decernotinib
Mechanism
Curator reviewed
Formula / weight
C18H19F3N6O · 392.386 g/mol (avg)
Also known as
Adelatinib
Code names
VRT-831509 · VX-509

Resolves to

Compound
UNIIMZK2GP0RHKCAS944842-54-0ChEMBLCHEMBL3039513PubChem59422203
Structure
InChIKeyASUGUQWIHMTFJL-QGZVFWFLSA-NSMILESCC[C@@](C)(NC1=CC=NC(=N1)C1=CNC2=NC=CC=C12)C(=O)NCC(F)(F)F
Targets
P52333JAK3

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Decernotinib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In